Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 2.20
- Piotroski Score 5.00
- Grade Neutral
- Symbol (BAX)
- Company Baxter International Inc.
- Price $36.48
- Changes Percentage (-0.29%)
- Change -$0.11
- Day Low $36.24
- Day High $36.68
- Year High $44.01
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
- Last Earnings 07/16/2024
- Ex-Dividend for 5/16 Dividend 08/30/2024
- Dividend Payable 10/01/2024
- Today N/A
- Next Earnings (Estimated) 11/08/2024
- Fiscal Year End N/A
- Average Stock Price Target $45.00
- High Stock Price Target $98.00
- Low Stock Price Target $30.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.08
- Trailing P/E Ratio -414.5
- Forward P/E Ratio -414.5
- P/E Growth -414.5
- Net Income $2.66 B
Income Statement
Quarterly
Annual
Latest News of BAX
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Baxter's North Carolina Facility Manufactures ~60% Of IV Fluids And Peritoneal Dialysis Solutions, Senator Demands Immediate Action To Protect Patient Care Amid Shortage
Baxter International's largest IV solutions facility in North Carolina shut down due to flooding from Hurricane Helene. Senator Klobuchar warns of a potential crisis as another facility in Florida is ...
By Yahoo! Finance | 2 weeks ago -
Does Baxter Stock Offer Any Room For Growth?
Baxter stock (NYSE: BAX) trades at $38, 50% lower than in February 2022. Its performance has been weaker than peers due to falling profit margins and business sale. Despite an uncertain market, analys...
By Forbes | 3 weeks ago -
Here's Why Baxter International (BAX) Slid in Q2
Parnassus Investments released the Q2 2024 investor letter for the Parnassus Value Equity Fund, reporting a -3.81% return. The fund's focus on AI-related IT investments and bargain opportunities is hi...
By Yahoo! Finance | 3 weeks ago
